CA2089207A1 - Compose tricyclique amphotere - Google Patents

Compose tricyclique amphotere

Info

Publication number
CA2089207A1
CA2089207A1 CA2089207A CA2089207A CA2089207A1 CA 2089207 A1 CA2089207 A1 CA 2089207A1 CA 2089207 A CA2089207 A CA 2089207A CA 2089207 A CA2089207 A CA 2089207A CA 2089207 A1 CA2089207 A1 CA 2089207A1
Authority
CA
Canada
Prior art keywords
same
tricyclic compound
disclosed
bronchial asthma
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2089207A
Other languages
English (en)
Other versions
CA2089207C (fr
Inventor
Yasuo Ito
Hideo Kato
Shingo Yasuda
Noriyuki Kado
Nobuhiko Iwasaki
Hiroyuki Nishino
Makoto Takeshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Japan Co Ltd
Original Assignee
Hokuriku Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical Co Ltd filed Critical Hokuriku Pharmaceutical Co Ltd
Publication of CA2089207A1 publication Critical patent/CA2089207A1/fr
Application granted granted Critical
Publication of CA2089207C publication Critical patent/CA2089207C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002089207A 1992-02-20 1993-02-10 Compose tricyclique amphotere Expired - Lifetime CA2089207C (fr)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP6940492 1992-02-20
JP069404/1992 1992-02-20
JP137602/1992 1992-05-01
JP137605 1992-05-01
JP13760592 1992-05-01
JP13760292 1992-05-01
JP27350692 1992-09-18
JP273506/1992 1992-09-18
JP32146792 1992-11-06
JP321467/1992 1992-11-06

Publications (2)

Publication Number Publication Date
CA2089207A1 true CA2089207A1 (fr) 1993-08-21
CA2089207C CA2089207C (fr) 1997-04-29

Family

ID=27524183

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002089207A Expired - Lifetime CA2089207C (fr) 1992-02-20 1993-02-10 Compose tricyclique amphotere

Country Status (10)

Country Link
US (1) US5334594A (fr)
EP (1) EP0556813B1 (fr)
JP (1) JP2974529B2 (fr)
KR (1) KR0140504B1 (fr)
AT (1) ATE160566T1 (fr)
AU (1) AU655869B2 (fr)
CA (1) CA2089207C (fr)
DE (1) DE69315363T2 (fr)
DK (1) DK0556813T3 (fr)
ES (1) ES2111086T3 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
US5801175A (en) * 1995-04-07 1998-09-01 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
WO1997009330A1 (fr) * 1995-09-01 1997-03-13 Hokuriku Seiyaku Co., Ltd. Cristal d'hydrate et son procede de preparation
JP3723927B2 (ja) * 2000-07-11 2005-12-07 日本ライナー株式会社 エポキシ樹脂を短時間で硬化する方法及び、該硬化方法によって得られたエポキシ樹脂硬化物による電磁波吸収方法
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
AU2004230380A1 (en) * 2003-04-15 2004-10-28 Fujiyakuhin Co., Ltd. Benzoxepino-11-piperidylidene compounds and process for production thereof
US7617820B2 (en) * 2004-06-15 2009-11-17 Smart Parts, Inc. Pneumatic paintball gun

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
DE68916699T2 (de) * 1988-04-28 1994-12-01 Schering Corp Benzopyridopiperidin, -piperidyliden und -piperazin-Verbindungen, Zusammensetzungen, Methoden zur Herstellung und Verwendung.
NZ238629A (en) * 1990-06-22 1993-09-27 Schering Corp Bis-benzo- or benzopyrido-cyclohepta (where z is c, o, s or n) piperidine, piperidylidene or piperazine compounds, medicaments and methods of preparation
AU2028892A (en) * 1991-05-23 1992-12-30 Schering Corporation Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use
EP0524784A1 (fr) * 1991-07-23 1993-01-27 Schering Corporation Composés de benzopyrido pipéridylidène, comme antagonistes du PAF

Also Published As

Publication number Publication date
KR0140504B1 (ko) 1998-06-01
AU3309793A (en) 1993-08-26
US5334594A (en) 1994-08-02
AU655869B2 (en) 1995-01-12
EP0556813A1 (fr) 1993-08-25
JP2974529B2 (ja) 1999-11-10
JPH06192263A (ja) 1994-07-12
EP0556813B1 (fr) 1997-11-26
KR960017669A (ko) 1996-06-17
ATE160566T1 (de) 1997-12-15
ES2111086T3 (es) 1998-03-01
DE69315363T2 (de) 1998-06-25
CA2089207C (fr) 1997-04-29
DK0556813T3 (da) 1998-08-10
DE69315363D1 (de) 1998-01-08

Similar Documents

Publication Publication Date Title
CA2012686A1 (fr) Traitement et composes utilises pour ledit traitement
CA2153979A1 (fr) Composes presentant une puissante activite d'antagonistes du calcium et d'antioxydants et leur utilisation en tant qu'agents cytoprotecteurs
CA2014545A1 (fr) Derives d'acide biliaire; methode de preparation desdits derives et compositions pharmaceutiques utilisant ces derives
CA2087540A1 (fr) Composition, methode et trousse pour potentialiser l'action antitumorale et traiter le cancer
CA2290918A1 (fr) Derives bicycliques heteroaromatiques utiles comme agents anticancereux
CA2067221A1 (fr) Derive pyrimidine a cycles condenses, procede pour sa preparation et preparation pharmaceutique en contenant comme ingredient actif
CA2521271A1 (fr) Derives de quinoline-2-one permettant de traiter des maladies des voies respiratoires
KR890005124A (ko) 세펨 화합물 및 이의 제조방법
CA2297011A1 (fr) Agent therapeutique ou prophylactique de traitement de la glomerulopathie
CA2099970A1 (fr) Compose pour le traitement du syndrome de sjoegren
CA2210492A1 (fr) Derives de l'acide neuraminique, leur preparation et leur utilisation medicale
CA2192555A1 (fr) Compose de 2-acylaminopropanol et composition medicinale
CA2126118A1 (fr) Derive de l'acide 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylique
CA2099867A1 (fr) Utilisation de 4,6-di-tert-butyl-5-hydroxy-1,3-pyrimidines substituees en 2 comme agents anti-inflammatoires
CA2112084A1 (fr) Composes antidepresseurs et antiparkinsoniens
CA2089207A1 (fr) Compose tricyclique amphotere
CA2126518A1 (fr) Utilisation de phenylalkylamines
CA2057734A1 (fr) Alkylester de glutathion du type oxyde
EP0095894A3 (fr) Dérivés de la 6-alpha-méthyle prednisolone
CA2032254A1 (fr) Derives de glycerol, mode de preparation et compositions therapeutiques en contenant
CA2058888A1 (fr) Derives d'acide phenoxyalkylcarboxylique et methode de preparation
CA2152191A1 (fr) Agent therapeutique pour le glaucome et agent hypotenseur oculaire
CA2392630A1 (fr) 2-amino-5,6-dihalo-3,4-dihydroquinazolines dotees de proprietes de reduction de la numeration des thrombocytes
CA2118425A1 (fr) Derive du benzothiazolesulfamide, son mode de preparation et son utilisation
CA2452920A1 (fr) Derives de benzo [g] quinoline destines au traitement du glaucome et de la myopie

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20130211